Navigation Links
Argos Therapeutics Secures $25 million Series D Financing to Commence Phase 3 ADAPT Study in Patients with Metastatic Renal Cell Carcinoma (mRCC) in Mid-2012
Date:4/24/2012

se. To address the challenge of the unique genetic profile of each patient´s disease and the genetic mutations of that disease, Argos loads the autologous dendritic cells with a sample of messenger RNA ("mRNA") isolated from the patient´s disease. Through this process, dendritic cells can potentially prime immune responses to the entire antigenic repertoire, resulting in an immunotherapeutic that is fully personalized for each patient's disease.

About Argos Therapeutics

Argos Therapeutics is a biopharmaceutical company focused on the development and commercialization of fully personalized immunotherapies for the treatment of cancer and infectious diseases based on its Arcelis™ technology platform. Using biological components from each patient, Arcelis-based immunotherapies employ the patient's dendritic cells to activate an immune response specific to the patient's disease. Argos' most advanced product candidates include AGS-003 for the treatment of metastatic renal cell carcinoma, or mRCC, and AGS-004 for the treatment of HIV. 

Contact:

David Schull or Andreas Marathovouniotis
Russo Partners LLC
(212) 845-4271 or (212) 845-4235
david.schull@russopartnersllc.com or andreas.marathis@russopartnersllc.com

Jeff Abbey
Argos Therapeutics
(919) 287-6308
jabbey@argostherapeutics.com

 


'/>"/>
SOURCE Argos Therapeutics Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Results From Argos Therapeutics Arcelis™ Immunotherapy Phase 2 Study for Treatment of Renal Cell Carcinoma (RCC) Accepted for Poster Presentation at Ninth International Kidney Cancer Symposium
2. Argos Therapeutics to Present Recent Clinical Developments and Corporate Overview at 18th Annual BioPartnering Europe
3. Argos Therapeutics to Present Overview of its Arcelis™ Dendritic Cell-based Immunotherapy, Participate in Panel Discussion at Inaugural Cancer Immunotherapy Conference
4. Argos Therapeutics to Present Potential of its Arcelis™ Immunotherapy as an Innovative, Effective Treatment for HIV at the APHA 138th Annual Meeting & Exposition
5. Interleukin (IL)-12 Secretion Can Predict Potency of Argos Therapeutics Arcelis™ Dendritic Cell (DC) Immunotherapy and Can Be Used as Potency Marker in Phase 3 Clinical Trial
6. Argos Therapeutics Arcelis™ Immunotherapy for the Treatment of Renal Cell Carcinoma (RCC) in Combination With Sunitinib Demonstrates Strong Immunologic Response That Correlates to Improved Clinical Outcomes
7. Argos Therapeutics Files Registration Statement for Proposed Initial Public Offering
8. Argos Therapeutics Late Scientific Co-founder Ralph Steinman, M.D., Awarded Nobel Prize in Medicine for Discovery of Dendritic Cells as Critical Sentinels of Immune System
9. Vicus Therapeutics to Present at the 234th American Chemical Society National Meeting in Boston, MA
10. Allos Therapeutics Initiates Study of PDX in Patients with Cutaneous T-Cell Lymphoma
11. Amicus Therapeutics Announces Second Quarter 2007 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/2/2015)... DUBLIN , Sept. 2, 2015 Research and ... "Pharmaceutical Regulatory Affairs in China (Basel, Switzerland - November ... This seminar will provide a detailed overview of the key ... , Hong Kong , Macau ... cover: - All important aspects of gaining ...
(Date:9/2/2015)... NEW YORK , Sept. 2, 2015  Seeger ... knee implant bellwether trial will commence October 13, 2015. ... 1995 using the 510K fast-track approval program, Zimmer NexGen ... The program only requires that companies provide evidence that ... approved product in order to gain permissions. ...
(Date:9/2/2015)... -- Research and Markets ( http://www.researchandmarkets.com/research/6x789c/new_eu ) has announced ... (London, UK - November 16-17, 2015)" conference to ... modules concerning Pharmacovigilance are a major departure in terms ... Europe . The intention of the course is ... how they overlap and fit together and what Companies ...
Breaking Medicine Technology:Pharmaceutical Regulatory Affairs in China Seminar: Basel, Switzerland - November 26-27, 2015 2Seeger Weiss LLP Reports That Zimmer NexGen Knee MDL Bellwether Trial Date Set For October 13, 2015 2
... 14, 2011 Micross Components, a leading global ... as General Manager of its US Products & ... product and business development, will play a leading ... its offerings to increase market share across several ...
... YORK and JERUSALEM, Sept. 14, 2011 Chiasma, Inc., a ... & CEO, will present an overview of the Company at ... New York, New York, on Monday, September 19, 2011 at ... an oral form of octreotide acetate being developed first for ...
Cached Medicine Technology:Micross Components Names Mike Deley as General Manager of US Products & Services Division 2Chiasma to Present at the UBS Global Life Sciences Conference 2
(Date:9/3/2015)... ... September 03, 2015 , ... ... be participating at the highly anticipated Mississippi Gulf Babypalooza on September 19, 2015. ... all over, from Gulfport, Biloxi, and beyond. We will be discussing setting up ...
(Date:9/3/2015)... ... September 03, 2015 , ... Local filmmakers and now co-hosts of ... Habernig from Path 11 Productions have had great success in launching their Path11 Podcast ... Hay House authors, Teal Swan who is the well known Spiritual Catalyst and Linda ...
(Date:9/3/2015)... ... ... Fashion designer Kim (29 years old, Honolulu, HI) designed her own successful transformation ... series “Extreme Weight Loss” Season 5 . Standing just 5’1” and weighing 279 ... motivation to transform when she designed a drop-dead-gorgeous dress and vowed she would do ...
(Date:9/2/2015)... ... September 03, 2015 , ... Each ... among America’s policymakers, public servants, activists, corporate executives, entrepreneurs, health care professionals, and ... year, that process led the magazine to tap the National League for Nursing’s ...
(Date:9/2/2015)... ... , ... According to an article published August 12 by International Business Times, a ... away with grand juries in cases meant to decide if a police officer used deadly ... jury decisions in Ferguson and New York City that absolved police officers of charges in ...
Breaking Medicine News(10 mins):Health News:State Farm Agent EJ Roberts to Help Expecting Mothers at the Mississippi Gulf Babypalooza 2Health News:Path 11 Podcast Now Features over 20 Metaphysical Discussions on iTunes and Growing 2Health News:Path 11 Podcast Now Features over 20 Metaphysical Discussions on iTunes and Growing 3Health News:New “Extreme Weight Loss” Video Blog from the CU Anschutz Health and Wellness Center: Kim Begins with the End in Mind and Designs a Fashionable Future 2Health News:New “Extreme Weight Loss” Video Blog from the CU Anschutz Health and Wellness Center: Kim Begins with the End in Mind and Designs a Fashionable Future 3Health News:NLN CEO Dr. Beverly Malone Named One of 100 Most Influential in Health Care 2Health News:NLN CEO Dr. Beverly Malone Named One of 100 Most Influential in Health Care 3Health News:Article on Recent Grand Jury Law Brings Increased Accountability to Wrongful Death Cases, says the Law Offices of Burg & Brock 2Health News:Article on Recent Grand Jury Law Brings Increased Accountability to Wrongful Death Cases, says the Law Offices of Burg & Brock 3
... the key to giving terminally ill patients the spiritual ... between patients, expectations and understanding when it comes to ... recommendations to improve this situation appear today, in the ... The terms ,spirituality, and ,spiritual care, are becoming buzzwords ...
... , THURSDAY, July 22 (HealthDay News) -- Cryptococcus gattii ... -- is an emerging infection in the Pacific Northwest, U.S. ... infections are rare -- only 60 cases have been reported ... researchers at the U.S. Centers for Disease Control and Prevention ...
... Jenifer Goodwin HealthDay Reporter , THURSDAY, July 22 ... like an outcast. At the coffee shop where he worked, ... caused his skin to redden, flake and itch like mad. ... an immune-suppressing medication given intravenously returned his skin to near-normal ...
... in many biological processes also may play a role in ... Southern California and the National Institute on Aging at the ... in the Journal of Neuroscience, agree with research ... 11. Both studies found that mice lacking the protein SIRT1 ...
... specific brain regions in female patients with irritable bowel syndrome ... abdomen, along with diarrhea, constipation or both. ... the study appears in the July issue of the journal ... IBS is associated with both decreases and increases in grey ...
... , WEDNESDAY, July 21 (HealthDay News) -- Many women ... vaginal birth in future pregnancies, say new guidelines from ... guidelines emphasize again that a trial of labor after ... one of the authors of the new guidelines, Dr. ...
Cached Medicine News:Health News:Relationships hold key to spiritual care 2Health News:Dangerous Fungus Now Endemic in Pacific Northwest: CDC 2Health News:Dangerous Fungus Now Endemic in Pacific Northwest: CDC 3Health News:Insurance Woes Can Add to Burden of Psoriasis 2Health News:Insurance Woes Can Add to Burden of Psoriasis 3Health News:SIRT1 gene important for memory 2Health News:Study finds structural brain alterations in patients with irritable bowel syndrome 2Health News:Study finds structural brain alterations in patients with irritable bowel syndrome 3Health News:Vaginal Delivery May Be OK After C-Section 2Health News:Vaginal Delivery May Be OK After C-Section 3
... system is a family of plates that ... for consistent, reliable fixation of plate to ... backout. This innovative design eliminates the need ... your screws and the swivel ring automatically ...
Investigational use spacer with Cantilever Transforminal Lumbar Interbody Fusion and instrumentation. For Investigational use only. 7 mm height....
The CRW system is the premier stereotactic system. The CRW system can be configured as a basic CT-only system, a CT/MR scanner-dependent system, or a high-level CT/MR scanner-independent system with ...
The unique MR-frame and its indicators are made of a highly tensile and fibre reenforced Epoxyd material....
Medicine Products: